
Merck Nears $10bn Acquisition of Lung Disease Biotech Verona Pharma
Merck is on the verge of finalizing a $10 billion deal to acquire Verona Pharma, a biotech company specializing in

Merck is on the verge of finalizing a $10 billion deal to acquire Verona Pharma, a biotech company specializing in






Get notified about new articles